Regarding the mRNA expression of COL1A1 and ACTA2 ( Figure 7 F,G), GFIPO led to an increasing trend, only having significant differences at 48 h in ACTA2 expression.
← all excerpts
Metabolic Dysfunction-Associated Steatotic Liver Disease in a Dish: Human Precision-Cut Liver Slices as a Platform for Drug Screening and Interventions.
1
—
—